Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection

Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.

Read More

Top 100 Best Sellers

​ Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial. Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.  Moneycontrol Latest News Read More